Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Avanir licenses dextromethorphan product for CNS indications

Aug. 16, 2000

Pravastatin's effects on stroke in MI patients

Aug. 16, 2000

Schwabe to provide Ginkgo biloba extract for NIH study

Aug. 16, 2000

New compounds interacting with 5-HT6 receptors under development at Merck KGaA

Aug. 11, 2000

Novel isochroman compound useful for Alzheimer's disease

Aug. 11, 2000

Elan and Pharmacia to collaborate on developing beta-secretase inhibitors

Aug. 11, 2000

Glutamate/serotonin interactions in prefrontal cortex explored

Aug. 11, 2000

Mice bred to develop neurofibrillary tangles for dementia research

Aug. 11, 2000

Spherons potentially linked to Alzheimer's disease

Aug. 11, 2000

Secretin studies in autism reported at pediatric gastroenterology conference

Aug. 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...